Skip to main navigation Skip to search Skip to main content

Yes-associated protein 1 in cancer: bridging mechanical transduction and epigenetic regulation

  • Tingting Liu
  • , Shuo Yu
  • , Lu Zhang
  • , Wenwen Ji
  • , Guangdong Wang
  • , Na Wang
  • , Mengcong Li
  • , Tinghua Hu
  • , Zhihong Shi
  • The First Affiliated Hospital of Xi’an Jiaotong University
  • The Second Affiliated Hospital of Xi'an Jiaotong University
  • Xi'an Jiaotong University

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations

Abstract

Yes-associated protein 1 (YAP1) and its paralog TAZ serve as central mechanotransductive transcription coactivators that integrate mechanical cues from the extracellular matrix, such as stiffness and fluid shear stress, with epigenetic modifications to drive oncogenic processes. They regulate diverse biological functions, including proliferation, metastasis, immune evasion, autophagy, ferroptosis, and metabolism. This review highlights how YAP1/TAZ signaling is modulated by mechanosensitive pathways (Integrin/FAK, Rho GTPases) and epigenetic mechanisms (m6A methylation, DNA methylation), contributing to therapy resistance and disease progression. Targeting the mechano-epigenetic axis of YAP1/TAZ offers promising therapeutic strategies for cancer treatment.

Original languageEnglish
Article number2562726
JournalCancer Biology and Therapy
Volume26
Issue number1
DOIs
StatePublished - 2025
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • epigenetic modifications
  • extracellular matrix
  • therapy resistance
  • Yes-associated protein 1

Fingerprint

Dive into the research topics of 'Yes-associated protein 1 in cancer: bridging mechanical transduction and epigenetic regulation'. Together they form a unique fingerprint.

Cite this